Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat

Journal of Pharmaceutical Sciences

Volumn 88, Issue 3, 1999, Pages 306-312

  Van Der Graaf, Pieter H ^c   Nilsson, Jonas ^a   Van Schaick, Erno A ^b   Danhof, Meindert ^c  

^a Pharmacia & Upjohn AB   (Sweden)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; DISTRIBUTION VOLUME; DRUG ACTIVITY; DRUG CLEARANCE; DRUG DEVELOPMENT; DRUG ELIMINATION; DRUG PROTEIN BINDING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT;

EID: 0033012368     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980294a     Document Type: Article

References (34)

1. Hansch, C.; Fujita, T. rho-sigma-pi Analysis. A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 1964, 86, 1616-1626.
2. van de Waterbeemd, H. Chemometric Methods in Molecular Design, VCH: Weinheim, 1995.
3. Kubinyi, H. The quantitative analysis of structure-activity relationships. In Burger's Medicinal Chemistry and Drug Discovery; Wolff, M. E., Ed.; John Wiley & Sons: New York, 1995; pp 497-571.
4. Kubinyi, H. QSAR and 3D QSAR in drug design. Part 2: Applications and problems. Drug Discovery Today 1997, 2, 538-546.
5. 2
6. Toon, S.; Rowland, M. Strucure-pharmacokinetic relationships among the barbiturates in the rat. J. Pharmacol. Exp. Ther. 1983, 225, 752-763.
7. Mayer, J. M.; van de Waterbeemd, H. Development of quantitative structure-pharmacokinetic relationships. Environ. Health Perspect. 1985, 61, 295-306.
8. Yamada, Y.; Ito, K.; Nakamura, K.; Sawada, Y.; Iga., T. Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/pharmacodynamic relationship. Biol. Pharm. Bull. 1993, 16, 1251-1259.
9. Gobburu, J. V. S.; Shelver, W. H. Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. J. Pharm. Sci. 1995, 84, 862-865.
10. Blackey, G. E.; Nestorov, I. A.; Arundel, P. A.; Aarons, L. J.; Rowland, M. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J. Pharmacokinet. Biopharm. 1997, 25, 277-312.
11. Herman, R. A.; Veng-Pedersen, P. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series. J. Pharm. Sci. 1994, 83, 423-428.
12. Cupid, B. C.; Beddell, C. R.; Lindon, J. C.; Wilson, L. D.; Nicholson, J. K. Quantitative structure-metabolism relationships for substituted benzoic acids in the rabbit: prediction of urinary excretion of glycine and glucuronide conjugates. Xenobiotica 1996, 26, 157-176.
13. Cramer III, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analyses (COMFA). 1. Effects of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
14. Goodford, P. Multivariate characterization of molecules for QSAR analysis. J. Chemom. 1996, 10, 107-117.
15. Geladi, P.; Kowalski, B. R. Partial least squares: a tutorial. Anal. Chem. Acta 1985, 185, 1-17.
16. Cecchetti, V.; Filipponi, E.; Fravolini, A.; Tabarrini, O.; Bonelli, D.; Clementi, M.; Cruciani, G.; Clementi, S. Chemometric methodologies in a quantitative structure-activity relationship study: the antibacterial activity of 6-aminoquinolones. J. Med. Chem. 1997, 40, 1698-1706.
17. IJzerman, A. P.; van der Wenden, E. M.; Roelen, H. C. P. F.; Mathôt, R. A. A.; Von Frijtag Drabbe Künzel, J. K. Partial agonists for adenosine receptors. In Perspectives in Receptor Research; Giardinà, D.; Piergentili, A.; Pigini M., Eds.; Elsevier Science B. V.: Amsterdam, 1996; pp 181-192.
18. 1 receptors. J. Pharmacol. Exp. Ther. 1997, 283, 809-816.
19. 6-cyclopentyladenosine in the rat J. Pharmacol. Exp. Ther. 1994, 268, 616-624.
20. 1 receptor in vivo. Br. J. Pharmacol. 1995, 116, 1957-1964.
21. 6-phenylisopropyladenosine (PIA) in conscious normotensive rats. J. Pharmacol. Exp. Ther. 1995, 273, 405-414.
22. 1 receptors in vivo. J. Pharmacol. Exp. Ther. 1997, 283, 800-809.
23. 1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, hemodynamic and EEG effects. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 827-837.
24. 1 receptor. Drug Design Discov. 1992, 9, 49-67.
25. 3 receptor subtype. J. Med. Chem. 1997, 40, 833-840.
26. Nilsson, J.; Homan, E. J.; Smilde, A. K.; Grol, C. J.; Wikström, H. A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides. J. Computer-Aided Mol. Design 1998, 12, 81-93.
27. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
28. Rekker, R. F.; De Kort, H. M. The hydrophobic fragmental constant: an extension to a 1000 data point set. Eur. J. Med. Chem. 1979, 6, 479-488.
29. Ghose A. K.; Crippen G. M. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. I. Partition coefficients as a measure of hydrophobicity. J. Comput. Chem. 1986, 7, 565-577.
30. Eriksson, L.; Johansson, E. Multivariate design and modeling in QSAR. Chemom. Intell. Lab. Syst. 1996, 34, 1-19.
31. Berman, J.; Halm, K.; Adkison, K.; Shaffer, J. Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput. J. Med. Chem. 1997, 40, 827-829.
32. Olah, T. V.; McLoughlin, D. A.; Gilbert J. D. The simultaneous determination of mixtures of drug candidates by liquid chromatography atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure. Rapid Commun. Mass Spectrom. 1997, 11, 17-23.
33. Korfmacher, W. A.; Cox, K. A.; Bryant, M. S.; Veals, J.; Ng, K.; Watkins, R.; Lin, C.-C. HPLC-API/MS/MS: a powerful tool for integrating drug metabolism into the drug discovery process. Drug Discovery Today 1997, 2, 532-537.
34. Nestorov, I. A.; Aarons, L. J.; Rowland, M. Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis. J. Pharmacokinet. Biopharm. 1997, 25, 413-448. JS980294A